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We report that during assembly of HPV16 pseudovirus (PsV) the minor capsid protein, L2, interacts with
the host nucleolar protein nucleophosmin (NPM1/B23). Exogenously-expressed L2 colocalized with
NPM1, a complex containing both proteins, could be immunoprecipitated, and L2 could redirect to the
nucleus NPM1 that was pharmacologically or genetically restricted to the cytoplasm. Coexpression of the
major capsid protein, L1, prevented both the colocalization and the biochemical association, and L1
pentamers could displace L2 from L2/NPM1 complexes attached to a nuclear matrix. HPV16 PsV that was
produced in a cell line with reduced NPM1 levels had signiﬁcantly lower infectivity compared to PsV
produced in the parental cell line, although the PsV preparations had comparable L1 and L2 ratios and
levels of encapsidated DNA. The PsV produced in NPM1-deﬁcient cells showed increased trypsin
sensitivity and exhibited decreased L2 levels during endocytosis. These results suggest a critical role for
NPM1 in establishing the correct interactions between L2 and L1 during HPV capsid assembly. A
decrease in cellular levels of NPM1 results in the formation of seemingly normal, but unstable, capsids
that result in a premature loss of L2, thus inhibiting successful infection. No role for NPM1 in HPV
infectious entry was found.
Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Papillomaviruses (PV) comprise a large family of non-
enveloped DNA viruses that can cause epithelial tumors of the
skin and mucous membranes. The replication of PV is intimately
linked to the differentiation program of the host epithelia with
progeny virions only being produced in the terminally differen-
tiated outer layers [1]. This complicated life cycle prevents the
ready analysis of some aspects of PV biology, including assembly.
The PV pseudovirus (PsV) system was developed to allow the
generation of large quantities of high quality, homogeneous PV
capsids that can express an encapsidated marker pseudogenome
[2]. PsV are produced in 293TT cells by trans expression of the two
PV capsid protein genes in conjunction with the marker plasmid,
leading to the formation of PsV by nuclear assembly of the capsid
and its packaging the marker pseudogenome. Puriﬁed PsV have
sufﬁcient homogeneity to enable cryo EM analysis and structure
reconstruction [3]. The icosahedral PsV particles are indistinguish-
able from authentic PV in both structural appearance and disulﬁde
linkages, and have been employed to identify key early steps in the
PV life cycle that occur at the plasma membrane and in the
cytoplasm and nucleus (reviewed in [4,5]). This in vitro PsV system
should also provide an experimentally tractable approach for
obtaining insight into essential processes during the nuclear
assembly of infectious PV capsids.
The PV protein shell consists of only two proteins: the major
capsid protein, L1, and the minor capsid protein, L2. L1 has the
capability of self-assembling into virus like particles (VLPs) which,
like PsV, resemble authentic capsids morphologically and immu-
nologically [6], and are the basis for the current HPV vaccines [7].
Therefore, L2 is considered dispensable for the gross capsid
assembly process. Although examination of BPV1 assembly in
cultured cells revealed the L2-dependent nucleation of assembling
capsids at the ND10 nuclear subdomain [8], this precise localiza-
tion was found to be not critical for assembly of HPV31 [9].
Additionally, for some PV types, including HPV16, L2 itself is not
essential for encapsidation of the marker pseudogenome during
capsid production [2]. However, L2 is essential for the efﬁcient
transduction of the marker plasmid during infection by PsV and by
authentic PV virions.
L2 has multiple critical roles during infectious viral entry, such
as guiding the encapsidated viral genome through the endosomal
system and trans-Golgi network to ND10 in the nucleus, where
efﬁcient transcription can occur [10–12].
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The ability of the L1/L2 capsid to orchestrate the stepwise
uncoating process and release of the L2–genome complex in the
host cell depends on the correct assembly of the virus capsid in the
cells that produce the infectious PsV. It is likely that host
chaperone proteins are recruited by the assembling virion to
mediate this process, however little about these potentially critical
interactions has been described.
Nucleophosmin (NPM1/B23) is an abundant nuclear phospho-
protein that resides predominantly in the nucleolus. It is involved
in multiple cellular processes, including DNA–histone formation,
nucleosome assembly, and biogenesis of ribosomal RNA and DNA
repair. Increasing evidence has also implicated NPM1 involvement
in other diverse viral processes within the nucleus (reviewed in
[13]). Here, we report on the role of NPM1 in HPV16 virion
assembly and infection, which we investigated because a yeast
two-hybrid screen identiﬁed an interaction between NPM1 and L2.
We ﬁnd that although NPM1 expression in the target cell is
dispensable for HPV16 infection, it plays a critical role during the
production phase of the HPV16 lifecycle, in that it interacts with L2
to promote assembly of conformationally correct infectious
capsids.
2. Materials and methods
2.1. Yeast two-Hybrid screen
The two-hybrid screen was done through a contract with
Myriad Genetics and the NCI using the Center for Cancer Research
core facilities. This automated process uses ProNet technology for
the large-scale identiﬁcation of protein-protein interactions based
on nuclear yeast two-hybrid methodology as previously described
in detail {Nguyen 2008}. HPV16 L2 amino acids 13–474 was used
as a bait protein. NPM1 was found to be a strongly interacting prey
within a breast cancer/prostate cancer-derived library.
2.2. Cell lines
HeLa, HaCaT and 293 TT cell lines were cultured in DMEM
media supplemented with 10% fetal bovine serum (FBS) and
penicillin/streptomycin (P/S). FD11 cells and CHOΔfurin cells,
obtained from Steven Leppla (NIAID, NIH) and David Fitzgerald
(NCI, NIH), respectively, were propagated in DMEM/FBS, P/S and
10 mM proline. NPM1-depleted cell lines were generated by
transduction of 293TT cells with lentivirus particles containing a
shRNA speciﬁcally targeted to NPM1 (TRCN0000062270, Sigma-
Aldrich). 293TT cells were plated at 5105 per well in a 12 well
plate. Following overnight adherence 10 μl of lentivirus stock and
5 μg/ml polybrene were added to the culture. The following day
cells were seeded to a 100 mm plate and supplemented with
2.5 μg/ml puromycin 24 h later. The selection was continuously
maintained during cell line expansion and culture. Twenty
puromycin-resistant colonies were expanded and analyzed for
NPM1 mRNA levels by quantitative PCR (primer set VHPS-6294,
RealTimePrimers.com). Western blot quantiﬁcation of NPM1 pro-
tein levels was performed for the three clones exhibiting the
lowest NPM1 mRNA levels. Lysate from 1105 cells was analyzed
using mouse anti-NPM1 (32–5200, Invitrogen) for detection.
2.3. Antibodies
The rabbit and rat polyclonal antisera recognizing HPV16 L1
capsids were previously described [14,15], as was the polyclonal
rabbit antiserum against full length L2 [16], the 11885 L2
epitopes [17] and the anti-L2 monoclonal antibodies, RG-1 (L2
amino acids 17–36) [18] and L2K-1 (L2 amino acids 64–81) [19].
The Camvir-1 antibody (Abcam) was used to detect HPV16 L1 on
Western blots. Nucleoli were detected with clone AE3 that has
been widely used to stain speciﬁcally the nucleolus (Leinco
Technologies). NPM1 antibodies utilized were 32–5200 (Invitro-
gen) for immunoprecipitation and Western blots and H-106 (Santa
Cruz) and AF5205 (R&D Systems) for immunoﬂuorescent localiza-
tion. The anti-LAMP-1 monoclonal antibody (H4A3) developed by
August and Hildreth was obtained from the Developmental
Studies Hybridoma Bank developed under the auspices of NICHD
and maintained by the Department of Biological Sciences at the
University of Iowa [20].
2.4. NPM1 expression plasmids
The NPM1 expression construct pEGFP-C2-ﬂag-NPM was kindly
provided by Xin Wei Wang (NCI, NIH) [21]. A 4 basepair insertion
(TCTG) at nucleotide position 865 corresponding to NPM1 mutant A
genotype [22] was generated with the Quikchange XL (Agilent
Technologies) using the primers 50 gctattcaagatctctgtctggcagtggaggaag
30 and 50 cttcctccactgccagacagagatcttgaatagc 30.
2.5. Pseudovirus production
PsV preparations were produced according to the protocol
published on the laboratory website (http://home.ccr.cancer.gov/
lco/plasmids.asp). Brieﬂy 293TT cells were transfected with the
bicistronic plasmid encoding HPV16 L1 and L2 proteins (p16sheLL)
or a carboxyl HA-tagged L2 (p16shellCHA), together with a
reporter gene plasmid encoding GFP (p8fwB). Assembled particles
were released by detergent lysis, matured in the presence of
25 mM ammonium sulfate and puriﬁed by ultracentrifugation
through an Optiprep step gradient [23]. Disulﬁde cross-linking to
assess PsV maturation was performed as previously described [23].
Brieﬂy, 10 ng of PsV was alkylated by treatment with 10 mM N-
ethylmaleimide (NEM, Pierce) in 10 mM sodium phosphate for
10 min at room temperature. The samples were then incubated in
gel loading dye containing 10 mM NEM for 10 min at room
temperature followed by 10 min at 65 1C. The samples were
electrophoresed through a 3–8% Tris-Acetate NuPage gel (Invitro-
gen) transferred to Immobilon membrane (Millipore). L1 species
were detected with the Camvir-1 antibody. L1 pentamers were
produced with the L1 assembly mutant C428S. Pentamers were
puriﬁed on an Optiprep step gradient (46%, 30%, 20%, 15%) by
centrifugation at 50,000 rpm for 1 h at 16 1C using an NVT65
rotor. Pentamer content was conﬁrmed by electron microscopy.
Purity and L1 content were assessed following protein staining of
SDS-Page gels with SimplyBlue SafeStain (Invitrogen). To assess
infection, PsV dilutions were added to HaCaT cells that had been
grown overnight at a plating density of 8103 cells per well in 96
well plates. The percent of GFP-transduced cells was determined
by ﬂow cytometric analysis after a 72 h infection period.
2.6. Immunoﬂuorescent staining
Cells were seeded onto glass No. 01 coverslips in a 24-well
plate at a density of 8104/well and cultured overnight. For
evaluation of internalized PsV, 20 ng of PsV was added to each
well and allowed to bind and internalize for 24 h. For detection of
transfected proteins, transfections were performed directly on the
plated cells and incubated for an additional 24 h prior to ﬁxation.
When indicated, TmPyP4 (Santa Cruz) was added to cultures 4 h
post-transfection at a ﬁnal concentration of 10 μM. Following this
incubation cells were ﬁxed in ice cold ethanol containing 15 mM
glycine and processed for immunoﬂuorescent staining as pre-
viously described [24] followed by inversion onto DAPI-
containing mounting solution (Prolong Gold, Molecular Probes).
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The method to detect the time-dependent cell surface exposure of
L2 epitopes has been previously described [25]. Brieﬂy, PsV were
incubated with HaCaT cells for 1 h, unbound virus was removed,
and either processed immediately or incubated for an additional
4 h. Antibody incubations were performed in the cold for 1 h with
rocking. Following incubation with the secondary antibody cells
were ﬁxed with 2% paraformaldehyde for 20 min at room tem-
perature. Cells were washed three times with PBS/200 mM glycine
and inverted onto DAPI-containing mounting solution (Prolong
Gold, Molecular Probes). All images were acquired with a Zeiss 780
confocal system interfaced with a Zeiss Axiovert 100 M micro-
scope. In Fig. 9, panels J–L are surface-rendered images processed
with Imaris software. Images were collated with Adobe Photoshop
software.
2.7. Electron microscopy
100 ng of PsV preparation was applied to a carbon ﬁlm grid
(CF300-Cu, Fisher Scientiﬁc) and stained with freshly ﬁltered 1%
uranyl acetate. Samples were imaged with an FEI Tecnai T12
transmission electron microscope.
2.8. Immunoprecipitation
293TT cells were transfected with either the bicistronic expres-
sion plasmid, p16sheLL, to express both HPV16 L1 and L2 or the
plasmid pul to express only HPV16 L2. After 24 h, cells were lysed
in immunoprecipitation buffer (50 mM Tris–HCl pH 8.0, 100 mM
NaCl, 50 mM NaF, 0.5% NP-40 and 0.1% SDS containing complete
protease inhibitor cocktail (Roche)) for 20 min on ice. Cellular
debris was removed by centrifugation. Lysates were incubated
with rabbit anti-NPM1 antiserum (Santa Cruz) and protein A/G
sepharose (Pierce) overnight in the cold with rocking. Immuno-
precipitated complexes were collected by centrifugation and
washed 4 times in immunoprecipitation buffer. The remaining
complexes were boiled in SDS PAGE sample buffer and resolved on
a 10% NuPage gel (Invitrogen) and transferred to an Immobilon
membrane (Millipore).
2.9. Trypsin stability of capsids
To determine sensitivity to trypsin digestion, 10 μl PsV (500 ng)
was incubated with 10 μl of 0.05% trypsin at 37 1C for the time
indicated. Following the digestion period, 4 μl of the PsV mixture
was processed for L1 detection and 16 μl was processed for L2
detection. Samples were boiled in SDS PAGE sample buffer and
resolved on a 10% NuPage gel (Invitrogen) and transferred to an
Immobilon membrane (Millipore). L1 was detected with Camvir-1
and L2 was detected with the rabbit anti-full length L2 antiserum.
2.10. L2 stability on cell surface and ECM
Biochemical detection of L2 on the cell surface was assessed by
incubating 15 μl PsV (750 ng) with HaCaT cells that had been
plated at a density of 2.5106 in 100 mm plates one day prior.
Incubation was performed in 8 ml of conditioned medium from
either FD11 or Δfurin cells for 4 h at 37 1C. Following this incuba-
tion cells were washed twice with PBS and incubated with 5 μl
rabbit anti-HPV16 capsid antiserum in 5 ml PBS containing 2% FBS
and 0.1% NaN3 at 4 1C with gentle rocking. Cells were then washed
twice with PBS and lysed in situ with 3 ml NP40 lysis buffer
(50 mM Tris–HCl pH 8.0, 150 mM NaCl, 1.0% NP-40 and protease
inhibitors) for 15 min at 4 1C with rocking. Lysate was retrieved
and cellular debris removed by centrifugation. Immune complexes
were isolated by incubation with protein A/G sepharose (Pierce)
overnight at 4 1C with rocking. The samples were processed for
Western analysis as described above. Alternatively, ECM was
prepared from HaCaT cells as previously described [17] and 1 μl
PsV (5 ng) incubated overnight at 37 1C with 75 μl of conditioned
medium from either FD11 or Δfurin cells. Following this incuba-
tion ECM was washed three times with PBS and PsV retrieved by
addition of NuPage LDS sample buffer (Invitrogen), boiled and
processed for L2 detection by Western analysis.
2.11. Matrix extraction of HeLa cells
Following transfection and TmPyP4 treatment as indicated for
each experiment cells were extracted according to the protocol of
Staufenbiel and Deppert [26]. Brieﬂy, monolayers were washed with
Kern-matrix buffer (KM buffer): 10 mM N-morpholinoethanesulfonic
acid; 10 mM NaCl; 1.5 mM MgCl2; 10% glycerol; complete protease
inhibitor cocktail. The ﬁrst extraction was performed for 30 min on
ice with KM buffer supplemented with 1% Triton-X100, 1 mM EGTA
and 5 mM dithiothreitol. Following this extraction buffer was
removed and cells were washed three times with KM buffer. The
second extraction was performed for 15 min at 37 1C with KM buffer
containing 50 μg/ml DNase I. Buffer was removed and cells were
washed three times with KM buffer. The third extraction was
performed for 30 min on ice with KM buffer containing 2 M NaCl,
1 mM EGTA and 5 mM DTT. Following this ﬁnal extraction cells were
washed with PBS and either ﬁxed immediately or incubated with L1
pentamers (5 μg/ml in PBS containing 5% FBS and protease inhibitor)
for 18 h at 37 1C prior to ﬁxation. Following ﬁxation immunoﬂuor-
escence was performed as described.
3. Results
3.1. NPM1 and L2 interaction
The PV pseudovirus (PsV) production system can produce
predominantly uniform assembled PsV particles that can be
viewed as acceptable surrogates of authentic wart-derived parti-
cles [10,23,27,28]. To better understand the mechanisms of
assembly, we examined the intranuclear localization of HPV16
capsid proteins during PsV assembly when they were co-
expressed. We also determined the distribution of L2 when it
was expressed without L1, as HPV16 L2 is expressed before L1
during HPV replication in vivo [29,30]. PV L2 proteins have a
propensity to accumulate at the nuclear subdomain ND10, as
determined by L2 colocalization with the deﬁning ND10 resident,
PML. During infectious entry, L2 leads the encapsidated genome to
this site, and following its trans expression, L2 is often localized at
ND10, at least in in vitro systems [8,10].
Here we found that relatively high expression of HPV16 L2
resulted in a heterogeneous nuclear staining pattern that included,
in addition to the deﬁned ND10 localization, a larger, more
globular accumulation of L2 or diffusely nuclear L2, as previously
demonstrated [31]. As some of the larger accumulations of L2
appeared to be vaguely nucleolar or encircling nucleoli, we also
examined whether some L2 might localize to nucleoli. The variety
of nuclear distributions is illustrated in the micrograph shown in
Fig. 1A. When we examined the L2 localization in conjunction with
an antibody speciﬁc for nucleoli, many L2-expressing cells were
found to contain L2 in this ring-like pattern, shown in red, that
encircles nucleoli, shown in green (Fig. 1B). We also examined the
nuclear distribution of L2 when co-expressed with L1. 293TT cells
were transfected with a bicistronic L1 and L2 expression plasmid
to ensure that all the transfected cells express both proteins. In the
presence of L1, the distribution of L2 was shifted greatly toward a
diffuse nucleoplasmic pattern, and the nucleolar-associated rings
were no longer evident (Fig. 1C).
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We were intrigued by the possibility that a host nucleolar
resident protein might be involved in the early steps of HPV16
assembly. Coincident with obtaining the L2 nuclear staining
results, Myriad Genetics performed a yeast 2-hybrid analysis for
our laboratory using HPV16 L2 amino acids 13–474 as a bait
protein. Nucleophosmin (NPM1/B23) was found to be a strongly
interacting prey within a breast cancer/prostate cancer-derived
cDNA library. NPM1 is an abundant nuclear phosphoprotein that
resides predominantly in the nucleolus. It is involved in multiple
processes; most interesting to us was its capacity to act as a
cellular chaperone. Additionally, it has been demonstrated to
participate in assembly of other viruses [32].
To conﬁrm this interaction can occur within mammalian cells,
we expressed either HPV16 L2 alone or in conjunction with L1 in
293TT cells by transfection and assessed the ability of an anti-
NPM1 antibody to immunoprecipitate L2 or an L2-containing
complex. We were able to immunoprecipitate HPV16 L2 in a
complex with endogenous NPM1 as shown in Fig. 2, lane 1.
However, we were unable to co-immunoprecipitate L2 with
NPM1 when L1 and L2 were co-expressed in the cells (Fig. 2, lane
2), although the L2 expression levels in the two conditions were
comparable (Fig. 2, lanes 3, 4). The lower band seen in lane 4 is due
to slight cross-reactivity of the antibody with the faster migrating
L1 protein. Given the reduced interaction in the presence of L1, we
did not expect NPM1 to be present in the mature PsV particle
preparation; however, we found low, but detectable, amounts of
NPM1 associated with the particle (Fig. 2, lane 6). This represents
the amount found in 300 ng of puriﬁed PsV, whereas lane 5 shows
the amount of NPM1 in 100 ng of HeLa cell lysate. The biological
signiﬁcance of this observation is uncertain and may represent
NPM1 associated with the minor fraction of malformed or incom-
pletely assembled capsids in the preparations.
Although NPM1 shuttles between the cytoplasm and the
nucleus, and within the nucleus it can shift between nucleoplas-
mic and nucleolar localizations, its steady state localization is
predominantly nucleolar [33]. Therefore, we examined the pattern
of endogenous NPM1 staining in 293TT cells expressing either only
L2 or both capsid proteins. The L2-transfected cells are shown in
Fig. 3, panels A–C, with NPM1 staining in the green channel
(panels A and C) and L2 staining in the red channel (panels B
and C). Varying degrees of colocalization of these two proteins
were seen in the L2-expressing cells. Most of the observed
colocalization occurred in nucleolar-like structures (indicated by
the arrow in panel C), while NPM1 appeared to have shifted from a
nucleolar distribution to an ND10-like pattern in a subset of cells
(indicated by the arrowhead in panel C). In cells displaying a
diffuse nuclear L2 distribution, no change in NPM1 localization
was evident (data not shown). It is also important to note that not
every cell with either an ND10 or a nucleolar-like L2 expression
pattern exhibited a noticeable shift in NPM1 localization. In the
untransfected cells, NPM1 was, as expected, found in a nucleolar
pattern with varying degrees of cytoplasmic staining. In the cells
that were transfected with the bicistronic L1 and L2 expression
plasmid, the distribution of L2 was shifted greatly toward a diffuse
nucleoplasmic pattern (Fig. 3, panels E and F). Interestingly, NPM1
did not colocalize with L2 under these conditions, and its dis-
tribution was similar in the untransfected and transfected popula-
tions (Fig. 3 panels D and F). This result is consistent with the
previous data shown in Fig. 2, where we demonstrated that co-
expression of L1 prevented the ability of L2 to co-
immunoprecipitate with NPM1. Therefore, we believe that the
predominant NPM1 interaction is with L2 prior to its association
with L1 during the PV capsid assembly process.
Fig. 1. L2 distribution following transfection. The majority of the L2 protein is located within the nucleus following expression via gene transfection. The variety of
distributions, illustrated by the micrograph shown in panel A, includes diffuse nuclear, ND10-like punctate nuclear and a distinct nucleolar-encircling pattern as indicated by
the arrows. In panel B we show the L2 staining (red channel) coincident with that of a nucleolar speciﬁc antibody (green channel). One example of L2 encircling a nucleolus is
indicated by an arrow. Note the L2-positive rings that deﬁne the nucleolar boundary. Panel C shows the diffuse nuclear localization of L2 that is observed when co-expressed
with L1. Nucleolar staining is shown in green, L2 is shown in the red channel. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
Fig. 2. L2 association with endogenous NPM1. 293TT cells were transfected with
either the gene for HPV16 L2 or the bicistronic expression plasmid leading to
expression of both capsid proteins. At 24 h post-transfection cell lysates were
prepared and immunoprecipitation was performed with a mouse anti-NPM1
antibody and the association of L2 determined by Western analysis with a rabbit
anti-L2 antiserum. As labeled, the ﬁrst lane shows the associated L2 isolated from
L2-only expressing cells, whereas the NPM1-associated L2 in the presence of L1 is
shown in the second lane. The L2 expression levels in the two conditions were
comparable as shown in next two lanes. An anti-NPM1 antibody was used for
detection of NPM1 in either 100 ng (total protein) of HeLa cell lysate or 300 ng of
puriﬁed HPV16 PsV (based on L1 amount).
P.M. Day et al. / Papillomavirus Research 1 (2015) 74–89 77
3.2. L2 dominantly affects NPM1 localization
These data led us to hypothesize that NPM1 was participating
in HPV16 capsid assembly through a transient nuclear interaction
with L2. To address this possibility we sought to investigate capsid
assembly in the absence of nuclear NPM1. As NPM1 participates in
diverse cellular processes, including the crucial control of ribo-
some biogenesis and centrosome duplication, and deletion of the
mouse NPM1 gene results in embryonic lethality [34], we initially
decided to pharmacologically diminish intranuclear NPM1 levels
instead of reducing total levels by gene silencing techniques.
The C-terminal domain of NPM1 binds to G-quadruplex DNA
with high afﬁnity, and this interaction mediates the nucleosomal
localization of NPM1. The porphyrin TmPyP4, a G-quadruplex
selective ligand, has been shown to prevent association of NPM1
with G-quadruplex DNA; following this treatment, NPM1 is dis-
placed from the nucleoli and primarily accumulates in the cyto-
plasm [35]. We ﬁrst analyzed the effect of TmPyP4 treatment on
NPM1 localization in HeLa cells. As expected, TmPyP4 treatment
for 24 h resulted in the relocalization of NPM1 to the cytoplasm. In
Fig. 4, panel A, untreated cells show a clear predominantly
nucleolar expression pattern, as we have shown for the 293TT
cells. In contrast, in the TmPyP4-treated cells, shown in panel B,
almost all of the detectable NPM1 has been relocalized to the
cytoplasm. When L2 was expressed under these two conditions,
we found that L2 localized well with NPM1 in the untreated cells
as expected (Fig. 4, panels C and D), but this was also found to be
the case with the TmPyP4-treated cells. As shown in Fig. 4, panels
E and F, in the L2-expressing cells, NPM1 relocalized to the
nucleus, whereas the untransfected cells showed continued cyto-
plasmic NPM1 distribution. When we examined the effect of L1
expression on NPM1 localization in these two conditions, we
found no colocalization of L1 with NPM1 in either instance, and
no effect on the localization of NPM1 in the treated cells (Fig. 4,
panels G and H). This result further conﬁrmed the speciﬁcity of the
L2-NPM1 interaction, but the dominant effect of L2 on the
localization of NPM1 precluded the utility of this method for
assessing the importance of NPM1 in PsV production. Similar
results were seen in 293TT cells (data not shown).
NPM1 has been identiﬁed as the most frequently mutated gene
in acute myeloid leukemia (AML) [36]. Although multiple NPM1
mutations have been described, they all have the common feature
of producing an altered reading frame that leads to the translation
of a mutant protein containing four additional C-terminal residues
that act as a nuclear export signal (reviewed in [37]). Thus all of
the AML mutations result in the cytoplasmic localization of NPM1.
Through oligomerization, expression of this mutated form of
NPM1 causes the displacement of wild-type NPM1 protein to the
cytoplasm. Therefore, we decided to examine the possibility that
overexpression of a mutant NPM1 would act functionally as a
dominant-negative to allow an evaluation of NPM1-deﬁcient
nuclear PsV assembly. We examined the localization of transfected
wild-type NPM1 or mutant NPM1 in 293TT cells. Due to the high
level of expression from the transfected expression constructs, it
was difﬁcult to assess the endogenous NPM1 in these experiments
(data not shown). However, nuclear localization of the wild type
transfectants (Fig. 5, panel A) and predominantly cytosolic locali-
zation of the mutant transfectants was clearly evident (Fig. 5,
Fig. 3. L2 and NPM1 colocalization. The NPM1 pattern was evaluated in 293TT cells that expressed either L2 (panels A–C) or L1 and L2 (panels D–F). In all cases NPM1
staining is shown in the green channel and L2 staining in the red channel. In the L2-expressing cells, colocalization can be seen in nucleolar-like structures (indicated by
arrow in panel C). A more subtle shift of NPM1 into L2þ punctate domains is seen in a subset of cells (indicated by arrowhead in panel C). Neither colocalization nor a shift in
NPM1 expression pattern was evident in the cells that expressed both capsid proteins. (For interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)
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Fig. 4. Effect of TmPyP4 treatment on NPM1 localization. NPM1 localization in untreated HeLa cells is shown in panel A. The cytoplasmic relocalization of NPM1 following
overnight treatment with 50 μM TmPyP4 is shown in panel B. Panels C–F show the co-staining of NPM1 (green channel) and L2 (red channel) following transfection with an
L2 expression plasmid. Colocalized L2 and NPM1 can be seen in nonnucleolar regions in the untreated conditions (panel C). The NPM1 staining is also shown singly in panel
D to enable better visualization of the colocalized regions. Strong nuclear colocalization is seen in both nucleolar and non-nucleolar patterns following TmPyP4 treatment
(panel E). Panel F shows only the green channel. Please note the exclusive cytoplasmic NPM1 in the untransfected cell. Expression of both capsid proteins prevents the
relocalization of NPM1 as shown in panels G and H. L2 staining is shown in the red channel. NPM1 staining is shown in the green channel. While L2 is diffusely nuclear in
both instances, NPM1 is nucleolar in the untreated cells (panel G) and cytoplasmic following TmPyP4 treatment (panel H). (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this article.)
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panel B). When L2 was co-expressed with the wild type NPM1
construct, L2 was seen to be encircling nucleolar NPM1 in addition
to some lesser colocalization with NPM1 in punctate nuclear
structures (Fig. 5, panels C and D). A similar dominance of L2
localization described above for the TmPyP4 treatment was also
evident in this experiment, with L2 causing the nuclear relocaliza-
tion of mutant NPM1. The colocalization of L2 and the mutant
NPM1 was clear in both punctate structures and nucleoli (Fig. 5,
panels E and F). The non-L2 expressing cells did not contain
nuclear NPM1. Similar results were evident in HeLa cells (data not
shown). The results conﬁrm the interaction of NPM1 with L2 and
dominant localization activity of L2. Unfortunately, the strength of
the L2–NPM1 interaction would prevent the development of this
system for analysis of PsV assembled in the absence of
nuclear NPM1.
3.3. L1 pentamers remove L2 from NPM1þ nuclear matrix
During virus assembly, it has been previously demonstrated
that L1 is translocated into the nucleus following capsomer
formation in the cytoplasm [29], and these preformed assembly
intermediates incorporate L2 and the genome within the nucleus.
Fig. 5. Localization of overexpressed wild type NPM1 and AML-mutant NPM1. 293TT cells were transfected with either the wild type NPM1 expression construct (panel A) or
the AML mutant form (panel B), both are fusion proteins with GFP. Please note that in panel A all NPM1 expression is conﬁned to the nucleus, whereas in panel B fewer
nuclear foci are obvious and diffuse cytoplasmic staining is seen. These cells were also co-transfected for L2 expression (panels C–F). L2 staining (red channel) with the wild
type NPM1 is shown in panel C. The single channel showing NPM1 staining for this image is shown in panel D. The colocalization of L2 and the mutant NPM1 is shown in
panel E, with the NPM1 staining shown singly in panel F. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
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Therefore we decided to see if L1 pentameric subunits could
displace L2 from NPM1, as this should mimic the biologically
relevant assembly cascade, with nuclear L2 and the subsequent
introduction of pentamers. To address this scenario, we treated L2-
transfected HeLa cells with TmPyP4 to induce strong nuclear
colocalization of NPM1 and L2 as shown in Fig. 4. The cells were
then subjected to matrix extraction through sequential exposure
to detergent, DNase and high salt. It was not possible to use this
extraction procedure with the poorly adherent 293TT cells. The
matrix extraction of untransfected cells demonstrated that nuclear
NPM1 was retained in cells that were not treated with TmPyP4
(Fig. 6, panel A), but the cytoplasmic NPM1 present in the
TmPyP4-treated cells was diminished (Fig. 6, panel B). However,
in treated cells that had been transfected with L2, NPM1 showed a
largely punctate nuclear distribution (Fig. 6, panel C). L2 was also
retained following the extraction procedure and colocalized with
NPM1 in these prominent nuclear foci (Fig. 6, panel D). Interest-
ingly, in many of these cells it appeared as if L2 formed a
“doughnut” encircling NPM1. Following application of L1 penta-
mers to the skeletal matrix of L2-transfected cells, we observed
two distinct distributions of L1 protein association. As seen in
Fig. 6, panel E, L1 staining was detected along cell borders and
faintly throughout the cell body in subset of cells and in other cells
L1 was associated with punctate nuclear foci similar to that
observed for L2 and NPM1 (in the presence of L2). It was striking
that following application of L1 pentamers the distribution of L2
showed an obvious shift from the characteristic punctate inclu-
sions to a diffuse nuclear distribution in many cells (compare
Fig. 6, panels F, no L1, and G, þL1). We quantiﬁed the L2
distribution between these two phenotypes in three independent
experiments and found that 65–68% of L2þ cells showed a diffuse
pattern following L1 pentamer application. This is compared to
26–34% in the cells that were not exposed to exogenous L1.
Therefore, exogenous pentamer application to the L2–NPM1 scaf-
fold can mimic the diffuse L2 phenotype, as seen in the presence of
L1 following co-expression via transfection, supporting the
hypothesis that L1 pentamers directly induce the release of L2
from NPM1-containing nuclear complexes. However, these data do
not prove that this scaffold is important for the generation of
infectious HPV PsV.
In these experiments, we also observed a distinct loss of L2-
associated NPM1 following L1 pentamer application. Although
punctate NPM1 was still visible following this treatment it was
necessary to adjust the channel gain for acquisition to obtain
adequate images. Fig. 6, panel H shows the L2 and NPM1 in cells
that were exposed to L1 pentamer, acquired at the identical gain
setting as the image shown for non-pentamer exposed cells in
Fig. 6, panel D. In Fig. 6, panel I we show the same cells as in panel
H, but with the increased gain setting. The L2–NPM1 interaction
appeared diminished and fewer L2 “doughnuts” seemed to be
formed. To conﬁrm these observations we analyzed Z-stacked series
from the various conditions and performed surface rendering on
single nuclei. L2, shown in red, is clearly found encircling NPM1,
shown in green in the absence of L1 pentamers (Fig. 6, panel J).
Fig. 6, panel K shows the same image processing on a nucleus from
the L1 pentamer-treated group. It is clear that the NPM1 is more
disorganized and not held within the L2 shell. This is consistent
with the model that association of L1 pentamers with L2 results in
the displacement of NPM1 from L2-containing nuclear foci.
3.4. NPM1 is involved in capsid assembly, but not in HPV PsV
infection
Due to the unsuitability of either over-expression of the AML
NPM1 mutant or TmPyP4 treatment to investigate NPM1 depletion
during HPV PsV assembly, we used an NPM1-speciﬁc shRNA to
derive NPM1 deﬁcient cell lines from the parental line 293TT. The
293TT cell line was established for the efﬁcient production of PV
pseudovirions (PsV), therefore assembly processes are most easily
studied in this context. Western blot analysis indicated that the
shRNA-derived cell lines have greatly reduced, although still detect-
able, levels of NPM1 (Fig. 7, panel A). As NPM1 participates in
multiple cellular functions critical to survival, the inability to obtain a
completely depleted cell line is not surprising. Additionally, the cells
tend to revert to higher NPM1 expression over prolonged passage,
even with maintained selection pressure (data not shown).
We ﬁrst evaluated the involvement of NPM1 in the process of
HPV infection by comparing the infection potential of the parental
293TT cells with one of the NPM-1 deﬁcient clones, clone 14,
which we designated TTC14. The cells were infected with an
identical titration series of HPV16 PsV. As seen in Fig. 7, panel B
there was no obvious decrease in the infection efﬁciency of TTC14.
Therefore we focused our attention on the hypothesis that NPM1
is involved in HPV16 PsV assembly.
When the ability of the wild type and NPM1-deﬁcient cell lines
to produce infectious HPV16 PsV was examined, we found that
HPV16 PsV could be produced from every cell line with reduced
NPM1 expression, including TTC14. Puriﬁed PsV showed typical
L1/L2 ratios, histone content (indicative of packaged nucleosomal
DNA), and intramolecular L1 disulﬁde bond formation (data not
shown). However, all of the PsV preps showed substantially
reduced infectivity compared to PsV produced in parallel in the
parental 293TT cells (Fig. 8, panel A).
3.5. NPM1-deﬁcient cells produce defective PsV particles
A larger PsV preparation was prepared and puriﬁed from TTC14
cells and, in parallel, from 293TT cells. As before, although the two
preparations had similar capsid protein levels, L1/L2 ratio and
histone association (Fig. 8, panel B), the infectivity of the PsV
preparation assembled in the TTC14 cells was only about 15% that
of the PsV produced in parental 293TT cells (data not shown).
When negatively stained PsV preparations were analyzed by
transmission electron microscopy, no gross structural differences
were evident, although this method is sensitive enough to distin-
guish between immature and mature PsV particles (Fig. 8, panels C
and D) [38]. We also conﬁrmed in both PsV preparations that the
internal L2 epitope aa 17–36 was inaccessible to the RG-1 mono-
clonal antibody, which recognizes this epitope and has previously
been shown to not immunoprecipitate mature HPV16 PsV under
conditions that can immunoprecipitate immature particles and
assembly intermediates [25] (Supplemental Fig. S1, panel A).
Therefore the TTC14 PsV particles were not grossly defective in
particle maturation.
A previous analysis showed that a brief digestion with trypsin
had little effect on mature, correctly folded HPV16 PsV particles
[38]. To determine if subtle conformational differences could be
discerned by trypsin sensitivity, we compared the trypsin sensi-
tivity of TT and TTC14 PsV by digestion for either 30 min or 3 h.
Detection of L1 following this treatment showed the appearance of
the same tryptic products in both preparations. However, the
degree of digestion was higher in the TTC14 preparation, as
indicated by the more intense lower bands (Fig. 9, panel A). The
examination of L2 showed a more dramatic difference between
the two preparations (Fig. 9, panel B), with a distinct digestion
product, migrating at approximately 50 kDa, being evident by
30 min in the TTC14 preparation, but not in the TT preparation.
At the later time point, L2 was greatly reduced in both prepara-
tions, but the decrease was greater in the TTC14 preparation. A
longer exposure of the L2 digestion lanes (Fig. 9, panel D) shows
the increased laddering of the L2 protein in the TTC14 PsV more
clearly. When L1-only PsV were assembled in these two cell lines,
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Fig. 6. L1 pentamers disrupt L2–NPM1 association. Matrix extracted HeLa cells are shown in all panels. Panel A shows the NPM1 localization in untreated HeLa cells. All
other panels show cells that were treated with TmPyP4 prior to extraction. Panel B shows NPM1 staining in untransfected cells, whereas the staining of L2-expressing cells is
shown in Panel C. The colocalization of L2 (red channel) and NPM1 (green channel) is shown in panel D. Please note the apparent localization of L2 around NPM1. Panel E
shows the detection of bound L1 following overnight application of L1 pentamers to the extracted matrix from L2-expressing cells. The comparison of panels F and G shows
the shift of L2 from a more punctate distribution without L1 pentamers (F) to a more diffuse distribution following L1 pentamer application (G). The detection of NPM1 and
L2 in L2-expressing cells following pentamer addition is shown in panels H and I. The conditions for image acquisition for panel H were identical to that for panel D (no
pentamers). The green gain was increased in panel I to allow visualization of NPM1. Nuclei from these two conditions analyzed by surface rendering are shown in panels J (no
pentamers) and K (þ pentamers). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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and compared for trypsin resistance, the differences were less
pronounced than seen for the PsV preparations containing both L1
and L2 (Fig. 9, panel C). This observation suggests that most of the
reduced trypsin resistance of L1 in the TTC14-produced capsids
was L2-dependent.
3.6. Entry of TT and TTC14 PsV
We then determined if there were any obvious differences in
the endocytosis and trafﬁcking of the PsV produced from the two
cell lines, by allowing PsV to enter HeLa cells for 24 h and
examining the localization of the two capsid proteins. For both
PsV preparations, L1 showed good colocalization with LAMP-1,
indicating successful delivery into the late endosomal/lysosomal
compartment, (Fig. 10, compare panel A [TT PsV] with panel B
[C14TT PsV]). In contrast, examination of the L2 distribution
following endocytosis showed striking differences between the
two PsV preparations. For the TT PsV, L2 was localized predomi-
nantly in perinuclear accumulations, most likely representing the
Golgi complex as previously described [11,12], and additionally in
small peripheral vesicles (Fig. 10, panel C). However, L2 from TTC14
PsV was only localized in sparse peripheral vesicles (Fig. 10, panel
Fig. 8. PsV assembly in NPM-1 deﬁcient cell lines. HPV16 PsVs containing a GFP-reporter plasmid were made in each of the cell lines. Puriﬁed PsV was equilibrated by L1
amount and assessed by ﬂow cytometry for infectivity following incubation with HaCaT cells for 72 h. Three dilutions were evaluated (panel A). The infection was reduced by
75–84% with C2 PsV, 97–99% with C14 PsV, and 92–93% with C19 PsV. The protein gel of 2 amounts of PsV from 293TT (lanes 1 and 2) and C14 (lanes 3 and 4) is shown in
panel B. The lower bands represent histones present on the packaged DNA. The two upper bands are the capsid proteins. The less abundant L2 migrates slightly more slowly
than L1. Electron microscopic analysis of negatively stained 293TT- and C14-produced PsV is shown in panel C and D, respectively.
Fig. 7. NPM1-deﬁcient cell lines. NPM1-deﬁcient cell lines were isolated by puromycin selection and assessed for mRNA levels by qPCR (data not shown). Three cell lines
were analyzed for NPM1 expression by Western blot analysis (panel A). The parental cell line 293TT cell line is shown in lane 1. Clones C2, C14 and C19 are shown in lanes 2,
3 and 4, respectively. The comparison of HPV16 PsV infection of clone C14 and the parental 293TT cell line is shown in panel B. Infection, in triplicate, with a dilution series of
HPV16 PsV containing a GFP reporter plasmid was analyzed by ﬂow cytometry following a 48 h infection period.
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D). Also, the amount of L2 appeared to be less after infection with
the TTC14 PsV, possibly due to aberrant trafﬁcking and subsequent
degradation or its becoming inaccessible to staining.
During infectious entry, conformational changes allow the
exposure of the amino terminus of L2 to cellular proprotein
convertases, most notably furin. Furin cleaves the extreme amino
terminus (at aa 12 for HPV16) and exposes the N-terminal cross-
neutralization epitope to antibodies [39,40]. We previously devel-
oped a method to assess this temporal epitope exposure on the
surface of cells [25]. To determine if the TTC14 PsV exhibit a deﬁcit
in this essential event, we compared L2 epitope exposure for the
two PsV preparations. PsV were adsorbed to HaCaT cells for 1 h at
37 1C, and the incubation was either terminated at this point or the
cells were washed and reincubated for a 4 h chase period. The
amount of PsV binding was determined by anti-L1 staining and the
extent of L2 exposure was also measured, using the RG-1 mono-
clonal antibody. For both PsV preparations, capsid binding at the
1 h time point was readily detected (Fig. 11, panels A and C), and,
as expected at this early time point, little L2 antibody binding
occurred (Fig. 11, panels B and D), although, we found slightly
increased L2 staining with the TTC14 PsV preparation (panel D). As
mentioned previously, RG-1 was incapable of recognizing these
capsids in solution, as evidenced by its inability to immunopreci-
pitate TT-derived PsV. Therefore, these results likely indicate a
change in conformation that occurs soon after cell interaction,
unlike with the TT PsV seen here and previously [25]. Following
the longer incubation time, the levels of cell surface L1 were
essentially unchanged for the two PsV preparations (Fig. 11, panels
E and G). As expected, the capsid conformational changes and
furin cleavage that occurred during this chase period allowed
antibody access to the L2 17–36 region in the case of the TT-
produced PsV (Fig. 10, panel F). In contrast, no signal was evident
for the TTC14 PsV (Fig. 11, panel H) at this later time point, despite
the slightly higher degree of staining at the 1 h time point. To
conﬁrm this result, we also examined the L2 staining with a
polyclonal serum that was raised against the 11–88 region of L2,
which produced ﬁndings similar to RG-1 (data not shown).
3.7. Loss of L2 from cell surface and ECM-bound PsV
Based on the microscopic analyses, we hypothesized that L2 is
somehow lost or released from the capsid during infection. The
loss or release could occur either during endocytosis, as found in
the initial experiment, or at the cell surface, as found in the second
experiment. To conﬁrm the L2 loss biochemically, we examined
the amount of cell surface L2 following PsV attachment and furin
cleavage. After binding the PsV to HaCaT cells for 4 h, the cell
surface-associated capsids were immunoprecipitated with an anti-
L1 antibody, and L1-associated L2 levels in the immunoprecipi-
tates were determined by Western blot analysis. In the micro-
scopic analysis shown in Fig. 11, only the L2 that has exposed RG-1
epitopes could give a positive antibody signal, whereas in this
experiment we would theoretically detect all of the capsid-
associated L2. Because of this difference, we also performed the
analysis with the addition of exogenous furin to ensure more
complete and rapid cleavage of L2, and potentially its loss as well.
As shown in Fig. 12, panel A, there was little difference in the L1
protein levels between the TT and TTC14 PsV samples, either with
or without exogenous furin. Even in the absence of exogenous
furin, there was a subtle decrease in the amount of L2 in the TTC14
preparation compared to the TT PsV, and this difference was
magniﬁed in the presence of furin (Fig. 12, panel B). Thus, these
results are similar to the microscopic ﬁndings. However, the
difference in the amount of L2 observed with the biochemical
method, which detects all L2 associated with L1 on the cell surface,
was smaller than that observed microscopically, which only
detected furin-cleaved L2. Ideally, we would determine the L2 loss
that occurs during the entire endocytic process, however we were
Fig. 9. Trypsin sensitivity of PsV. The trypsin resistance of TT and TTC14 PsV preparations was evaluated. Puriﬁed PsVs were incubated with an equal volume of 0.05% trypsin
for either 30 min or 3 h and compared to untreated samples by Western blot analysis. Panel A shows the anti-L1 immunoblot. Untreated samples are in lane 1, the 30 min
treatment is shown in lane 2, and the 3 h treatment is lane 3. The source of the PsV is indicated above the lanes. Note the increased intensity of the lower bands in the
trypsin-treated TTC14 lanes. Panel B shows the detection of L2 following the same treatment regimen. Please note the increase in the number of trypsin digestion products in
the TTC14 PsV sample following 30 min incubation and near complete loss of L2 by 3 h. Panel D shows a longer exposure of the same immunoblot to allow greater
appreciation of the differences between the PsV preparations. The boxed area encompasses the regions to compare between the two PsV preparations. The untreated lanes
were cropped out to prevent visual interference from over-exposure. Panel C shows the anti-L1 blot for the same protocol using L1-only particles prepared from the two cell
lines. The differences between the two preparations are less pronounced than that seen with the L2-containing PsV (compare to panel A).
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not able to reliably detect L2 from internalized PsV when we
added a reasonable amount of PsV per cell; even a dose of 15,000
capsids per cell was not adequate following an overnight incuba-
tion (data not shown).
As an alternative biochemical method, we examined the PsV
preparations following attachment to extracellular matrix (ECM)
derived from HaCaT cells. HPV16 PsV has been shown to bind well
to this matrix, and this interaction allows the necessary conforma-
tional changes to the HPV16 capsid that expose the furin cleavage
site on the L2 N-terminus [17]. The addition of cell-free exogenous
furin to these bound PsV allows furin cleavage to occur on the ECM
without any need for host cell interaction. For this experiment, we
incubated the two PsV preparations with ECM with or without
exogenous furin and evaluated L2 loss. We used PsV that con-
tained a carboxyl-HA tagged L2 protein in order to assess the loss
of full length L2 versus the potential clipping of the more amino-
terminal epitope that we had examined in the previous experi-
ments. Following the overnight incubation necessary to obtain
complete furin digestion of L2, we saw no difference in matrix-
bound L1 protein levels between the two PsV and no detectable
change in L1 levels due to exposure to furin (Fig. 12, panel C).
However, we saw a furin-dependent decrease in the amount of
matrix-bound L2 in the TTC14 PsV that was evident with either the
anti-HA antibody(Fig. 12, panel D), indicating loss of the entire L2
protein, or antibody L2K-1, which recognizes an epitope within
amino acids 64–81 of L2 (Fig. 12, panel E). No loss of L2 was
evident in the TT PsV preparations with either antibody. A slightly
faster migrating band was evident in both PsV preps in the
conditions that were exposed to exogenous furin. This band likely
represents detection of the furin-cleaved L2 following the loss of
the N-terminal end. The results indicate that L2 is less stably
associated with capsids produced in NPM1-deﬁcient cells after
they have undergone HPSG-induced conformational changes and
furin cleavage.
4. Discussion
The importance of L2 for the generation of infectious PV virions
has long been appreciated. Although L2 is not critical for the
assembly of the icosahedral capsid, it is necessary for correct
delivery of the viral genome into the host cell, and for many HPV
types it is also essential for the encapsidation of the genome
(reviewed in [41]). What has been little understood is how L2 and
the L1 pentamers assemble within the nucleus. L1 protomer to
pentameric capsomer assembly occurs in the cytoplasm [29].
Assembled pentamers are then translocated into the nucleus for
subsequent association with L2 and the viral genome. A require-
ment for the chaperone Hsc70 in the nuclear translocation of L2
has also been described [42]. Within the nucleus Hsc70 and the
co-chaperone Hsp40 are found in a complex with L2, but are
displaced during later assembly processes, as the chaperone
proteins are not associated with the fully assembled capsid. It
has been suggested that Hsc70 may participate in the incorpora-
tion of L2 or genome into the viral capsid. More recently the
sumoylation of L2 was demonstrated [43]. This modiﬁcation was
only present in the absence of L1, so it would presumably make an
early contribution to the assembly process or L2 localization prior
Fig. 10. PsV endocytosis. HeLa cells were infected for 24 h with PsV from either TT cells (panels A and C) or TTC14 cells (panels B and D). Colocalization of L1 (green channel)
and the late endosomal/lysosomal marker LAMP-1 (red channel) is shown in panels A and B. The distribution of L2 is shown in panels C and D; note the perinuclear
distribution of L2 in panel C. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 11. Detection of cell surface L2. PsVs were allowed to bind to HaCaT cells at 37 1C for 1 h. Cells were washed and stained prior to ﬁxation with either an anti-L1 antiserum
or an anti-L2 antibody, RG-1, which recognizes the 17-36 epitope. TT PsV is shown in panels A (L1) and B (L2), while C14 PsV is shown in panels C (L1) and D (L2). Cells were
also processed following a 4 h chase period. During this time L1 staining remains constant; panel E shows TT PsV and panel G shows C14 PsV. Increased L2 antibody binding
on TT PsV is shown in panel F. The lack of anti-L2 reactivity on C14 PsV is shown in panel H.
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to assembly. Aside from these studies, there has been a dearth of
experimental evidence on the host contribution to PV assembly. In
the current work, we show that the NPM1/B23, a nucleolar
phosphoprotein, plays an important role in this process.
It has become increasingly evident that the nucleolus has
diverse functions beyond its initially assigned role in ribosome
biogenesis (reviewed in [44]). The composition of nucleoli is
dynamic during cell cycle progression and signaling events impor-
tant during normal growth conditions [45]. They are also greatly
affected by conditions of cell stress due to environmental condi-
tions, disease, or viral infection. The ever-growing nucleolar
proteome presently contains more than 4500 entries, including
an abundance of chaperone proteins, a subset of which has
recently been termed nucleolar multitasking proteins (NoMPs)
[46]. NoMPs act not only as RNA or protein chaperones, but also
contribute fundamentally to nucleolar organization and function.
NPM1/B23 has been designated a NoMP due its numerous and far-
reaching functions.
To the growing list of NPM1 functions, we would add assembly
of infectious HPV16 PsV. Based on the accumulated data, we
envision that NPM1 plays an early role in the assembly process.
L1 expression prevents or reverses the association between L2 and
NPM1, and we have also shown that L1 expression shifts the
localization of L2 towards a more nucleoplasmic distribution
without an obvious coincident shift in NPM1 localization, whereas
in the absence of L1, L2 frequently encircles the nucleoli. NPM1
could act as a chaperone to ensure proper folding of nuclear L2
and/or act as a scaffold to position L2 for proper interaction with
L1 pentamers. It is intriguing that NPM1 also possesses a penta-
meric structure. We can envision an L2–NPM1 complex initiating
an assembly scaffold, possibly positioning L2 correctly within a
pentameric mold, around which L1 pentamers could accrete,
displacing NPM1 during the process. Indeed when we add exo-
genous pentamers to an L2–NPM1 scaffold on extracted cell
matrices, we can visualize the displacement of L2 and diffuse
relocalization. Additionally, in the nuclei that continue to bear
punctate L2, the interaction with NPM1 appears to be decreased
and disrupted. Although low levels of NPM1 are present in mature
PsV capsid preparations, this NPM1 may be associated with the
small amounts of partially assembled or misassembled capsid
structures present, and we doubt that it is functionally signiﬁcant.
It is unclear if NPM1 functions directly in PV assembly or by
recruitment of other chaperones. As L2 modiﬁcation by Sumo 2/3
could inﬂuence protein-protein interactions, we considered the
possibility that L2 sumoylation could be involved in L2–NPM1
interactions. However, no differences in L2 association with Sumo
2/3 in the 293TT and C14TT cell lines were detected (data not
shown). Also the previously described L2 sumoylation-defective
mutant and wild type L2 could interact equally well with NPM1
(data not shown). We similarly found no difference in the nuclear
relocalization of Hsc70 in the presence of L2 between the two cell
lines (data not shown).
Lack of adequate levels of NPM1 clearly has a negative effect on
the production of infectious particles, although there was no
obvious defect based on EM analysis, capsid protein ratio and
DNA encapsidation. However, although we found no difference in
the levels of disulﬁde bonding within the capsids (Supplemental
Fig. S1, panel B), capsid stability was clearly affected as trypsin
sensitivity was increased, with an almost complete loss of L2
observed in this in vitro assay. L2 was also lost from the capsid
during endocytosis. We further showed that this reduction in L2
could occur at the cell surface following furin cleavage, or
subsequent to furin cleavage following ECM attachment. Thus
we postulate that NPM1 functions to ensure that L2 is properly
folded/positioned in association with the L1 capsid shell such that
it remains ﬁrmly attached to the capsid after the initial HSPG-
induced conformational change and removal of the N-terminus of
L2 by furin cleavage. There is evidence for an involvement of
Cyclophilin B in mediating L2 conformational changes that allow
furin cleavage, as this occurs prior to our observed loss of L2, we
do not anticipate the involvement of this host chaperone in the
process [47].
Although L2 can clearly associate with endogenous NPM1,
which is predominantly nucleolar, it seems that L2 has a greater
propensity to interact with non-nucleolar NPM1, as evidenced by
the TmPyP4 treatment and NPM1 trans expression experiments.
With both methods of NPM1 delocalization, nearly complete
nuclear colocalization with L2 could be observed. This is strong
Fig. 12. Biochemical detection of L2 following cell surface or ECM PsV binding. Panels A and B show the immunoblot analysis of PsV associated with the HaCaT cell surface.
PsV were bound to HaCaT cells for 4 h at 37 1C either in conditioned medium from either FD11 cells (indicated by – symbol above the lane) or from Δfurin cells (indicated by
aþsymbol). Cell surface PsV were immunoprecipitated by application of an anti-L1 polyclonal serum prior to cell lysis and analyzed for either L1 (panel A) or L2 (panel B)
protein content. Camvir-1 was used for L1 detection and the RG-1 (17–36) antibody was used for L2 detection. Panels C–E show the analysis of PsV bound to HaCaT-derived
ECM. PsV containing C-terminally HA-tagged L2 were bound to the ECM for 18 h at 37 1C either in conditioned medium from FD11 cells or Δfurin cells. Panel C shows the
detection of L1, panels D and E show the detection of L2 with either anti-HA (panel D) or with L2K-1, a monoclonal antibody reactive against an epitope within amino acids
64–81.
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evidence of a speciﬁc interaction between the two proteins. The
relocalization of cytoplasmic NPM1 was prevented with co-
expression of L1, providing further indication of a mutually
exclusive L2 interaction. As to why the enhanced interaction with
delocalized NPM1 occurs; perhaps only a subset of nuclear NPM1
is available for L2 binding, because of strong mutually exclusive
association with other nuclear proteins, whereas following de
novo NPM1 synthesis or delocalization of NPM1, L2 can associate
with a larger pool of protein. It is also possible that L2 interacts
more strongly with monomeric NPM1, which is present in lower
amounts than oligomeric NPM1 and is associated with nucleo-
plasmic accumulation [48].
Other virus proteins, from a broad distribution of virus types,
have been demonstrated to interact with NPM1. In some instances,
NPM1 affects viral transcription by chaperoning viral proteins to
initiate promoter interactions, as is seen with EBV [49]. In other
cases, although NPM1 expression is necessary for viral replication
and a direct interaction with a viral protein has been determined,
the mechanism by which NPM1 promotes infection is not yet
understood. This is the case with Japanese Encephalitis Virus and
Newcastle disease virus [50,51]. The nucleolus has been described
as the site of assembly for AAV2 [52]. However, it is currently
unclear which host nucleolar proteins are necessary to complete
the assembly reaction for this virus.
Among the reported roles of NPM1 in viral infection, its
interaction with adenovirus has the most parallels to what we
have observed with HPV16. NPM1 is essential for adenovirus
replication in normal cells and has been shown to interact
critically with protein V, which is involved in capsid assembly.
NPM1 is not incorporated into the fully assembled particle, but is
found to be associated with empty particles, suggesting a scaffold-
ing function [32]. No particle formation was detected in normal
cells infected with a mutant virus encoding a protein V that was
unable to bind NPM1. For HPV16, we demonstrate a transient
association of NPM1 with L2 that is resolved early in the assembly
process. However, this early interaction between L2 and NPM1 is
not required for production of grossly normal capsids, but instead
it promotes subtle alterations in the conformations of L2 and L1 in
the assembled capsids. We provide strong evidence that the L2 in
defective PsV produced in the presence of reduced NPM1 levels
prematurely releases from the capsid at early time points during
infection, which abrogates its ability to mediate the nuclear
delivery of the viral genome necessary for successful infection.
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